MetaCap

GT Biopharma Insider Trades

NASDAQ: GTBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.96-0.22 (-6.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

GT Biopharma insider activity

No GT Biopharma insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Breen Michael Martin (Executive Chairman/Interim CEO) reporting a transaction in 200,000 shares at $0.287 on Aug 11, 2023. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GTBP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GTBP insider transactions

GT Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Aug 11, 2023Ohri ManuCFO & Secretaryother200,000$57.40KForm 4
Aug 11, 2023Ohri ManuCFO & Secretaryother200,000$57.40KForm 4
Aug 11, 2023Ohri ManuCFO & SecretaryAward200,000$57.40KForm 4
Aug 11, 2023Breen Michael MartinExecutive Chairman/Interim CEOAward200,000$57.40KForm 4
Apr 11, 2023Breen Michael MartinExecutive Chairman/Interim CEOBuy50,000$25.00KForm 4
Apr 6, 2023Ohri ManuCFO & SecretaryBuy50,000$25.00KForm 4
Jul 15, 2022Ohri ManuCFO & Secretaryother100,000—Form 4
Jul 15, 2022Ohri ManuCFO & Secretaryother100,000—Form 4
Jul 15, 2022Ohri ManuCFO & SecretaryAward100,000—Form 4
Jul 15, 2022Breen Michael MartinExec. Chair. and Interim CEOAward278,058—Form 4
Feb 25, 2021Breen Michael MartinDirectorConversion9,859$33.52KForm 4
Feb 25, 2021Breen Michael MartinDirectorConversion40,243$136.83KForm 4
Feb 16, 2021Wendel BruceDirectorAward347,572—Form 4
Feb 16, 2021Breen Michael MartinDirectorAward278,058—Form 4
Feb 16, 2021Berk GregoryDirectorAward278,058—Form 4
Dec 22, 2020Weldon Steven WFormer Officer and DirectorSale47,978$19.19KForm 4
Dec 22, 2020Wendel BruceDirectorBuy441$3.85KForm 4
Dec 22, 2020Wendel BruceDirectorBuy1,374$12.19KForm 4
Dec 21, 2020Weldon Steven WFormer Officer and DirectorSale35,722$12.15KForm 4
Dec 21, 2020Weldon Steven WFormer Officer and DirectorSale50,000$16.50KForm 4
Dec 21, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.00KForm 4
Dec 18, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.00KForm 4
Dec 17, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.50KForm 4
Dec 17, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.00KForm 4
Dec 16, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.00KForm 4
Dec 15, 2020Weldon Steven WFormer Officer and DirectorSale50,000$16.00KForm 4
Dec 15, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.00KForm 4
Dec 15, 2020Weldon Steven WFormer Officer and DirectorSale50,000$15.00KForm 4
Dec 14, 2020Weldon Steven WFormer Officer and DirectorSale46,300$13.43KForm 4
Dec 14, 2020Weldon Steven WFormer Officer and DirectorSale50,000$14.50KForm 4
Dec 14, 2020Weldon Steven WFormer Officer and DirectorSale50,000$14.00KForm 4
Dec 11, 2020Weldon Steven WFormer Officer and DirectorSale50,000$13.00KForm 4
Dec 11, 2020Weldon Steven WFormer Officer and DirectorSale50,000$12.50KForm 4
Nov 16, 2020Wendel BruceDirectorBuy3,268$10.26KForm 4
Jun 2, 2020Cataldo TonyCEOSale4,234,320$4.23KForm 4
May 13, 2020Weldon Steven WCFOSale2,269,708$2.27KForm 4
Aug 14, 2019Cataldo TonyCEOAward7,000,000—Form 4
Aug 14, 2019Weldon Steven WCFOAward4,500,000—Form 4
Feb 6, 2019Cataldo TonyDirectorSale800,000$800Form 4
Feb 1, 2019Urbanski Raymond W.CEOSale176,980$176.98Form 4
Nov 2, 2017Cataldo TonyExecutive ChairmanGift3,000,000—Form 4
Nov 2, 2017Cataldo TonyExecutive ChairmanGift100,000—Form 4
Nov 2, 2017Cataldo TonyExecutive ChairmanGift200,000—Form 4
Sep 1, 2017Weldon Steven WCFOAward2,566,835—Form 4
Sep 1, 2017Cataldo TonyExecutive ChairmanAward5,129,660—Form 4
Apr 5, 2016BRISTOL INVESTMENT FUND LTD10% Ownerother250,000—Form 4
Apr 4, 2016BRISTOL INVESTMENT FUND LTD10% OwnerSale675,000$205.03BForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related